why choose us

First received: August 09, 2022

Clinical Trial: A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Open Angle Glaucoma, Ocular Hypertension

Study Type: INTERVENTIONAL


Official Title: An Open-Label, Long-Term Phase III Study of STN1012600 Ophthalmic Solution Alone and in Combination With Timolol Ophthalmic Solution, in Subjects With Open Angle Glaucoma or Ocular Hypertension (Angel

Brief Summary: To evaluate safety and the ocular hypotensive effect of STN1012600 ophthalmic solution 0.002% alone or in combination with Timolol ophthalmic solution 0.5% for 52 weeks in subjects with open angle glaucoma or ocular hypertension.

Read more